Table of Contents - Volume 12, Issue 22



October 26, 2021

View the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 22. Research Paper (Cover) - “P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses” Research Paper - “Dishevelled-1 DIX and PDZ domain lysine residues regulate oncogenic Wnt signaling” Research Paper - “THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma” Research Paper - “Comparison of MET gene amplification analysis by next-generation sequencing and fluorescence in situ hybridization” Review - “Emerging approaches of wound healing in experimental models of high-grade oral mucositis induced by anticancer therapy” Editorial - “Future directions for immunotherapy in meningioma treatment” (PDF Download) Editorial - “Clinicopathological utility of human epidermal growth factor receptor 2 (HER2)-heterogeneity for next-generation treatments of triple-negative breast cancer” (PDF Download) Keywords - cancer vaccine, dishevelled (DVL), next-generation sequencing (NGS), oral mucositis, meningioma, immunotherapy, HER2 low, pancreatic cancer, breast cancer, non-small cell lung cancer (NSCLC), colorectal cancer, cancer, science, research, oncology About Oncotarget Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology. To learn more about Oncotarget, please visit or connect with: SoundCloud - Facebook - Twitter - LinkedIn - Instagram - YouTube - Pinterest - Reddit - Oncotarget is published by Impact Journals, LLC. Please visit or connect with @ImpactJrnls Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

Cancer Research

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.